Immunome, Inc.IMNMNASDAQ
LOADING
|||
Alerts
Want to monitor IMNM?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor IMNMWant to monitor IMNM?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor IMNMImmunome is a biopharmaceutical company that utilizes its proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics that are designed to change the way diseases are treated. The company's initial focus is on developing therapeutics to treat oncology and infectious diseases, including COVID-19. Immunome's proprietary discovery engine identifies novel therapeutic antibodies and their targets by leveraging the highly educated components of the immune system, memory B cells, from patients whose bodies have learned to fight off their disease.